Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Hematology · Emberger Syndrome

Understanding Emberger Syndrome (GATA2 Deficiency)

At a Glance

Emberger syndrome is a rare condition caused by a GATA2 gene change that can lead to hearing loss, lymphedema, immune problems, and a high risk of bone marrow disease. Regular blood and bone marrow monitoring helps guide timely treatment.

Emberger syndrome, also known as Deafness-Lymphedema-Leukemia Syndrome, is a very rare genetic condition that affects multiple systems in the body simultaneously. It is caused by a pathogenic variant (mutation) in the GATA2 gene [1][2]. This gene provides instructions for a protein that acts like a “master switch” for the development and maintenance of blood cells, the immune system, and the lymphatic system [3][4].

Because it is so rare, most local doctors may never have seen a case. It is considered part of a broader group of disorders called GATA2 deficiency [1]. While the symptoms can feel overwhelming, understanding how they are connected is the first step in managing you or your child’s care.

What Varies from Person to Person: Symptoms and their severity vary widely, even among family members with the exact same mutation.

A Multisystem Condition

The GATA2 gene is essential for building several parts of the body, which is why Emberger syndrome affects more than one system:

  • The Bone Marrow: The “factory” where blood is made. In this syndrome, the factory can struggle to produce enough healthy cells [1].
  • The Immune System: Specifically, the body may lack certain white blood cells like monocytes, B cells, and Natural Killer (NK) cells [5][6]. This makes it harder for the body to fight off specific infections, such as viruses (like HPV) or unusual bacteria [7].
  • The Lymphatic System: This system moves fluid through the body. The mutation can disrupt lymphatic development, causing fluid to build up (swelling) [8].
  • Hearing: The gene is also involved in the development of the inner ear, leading to hearing loss [9].

Common Symptoms and When They Appear

The timing of symptoms can vary widely [1].

Early Signs: Hearing and Swelling

Hearing loss and lymphedema (chronic swelling) are characteristic features. Sensorineural hearing loss—a type of hearing loss caused by inner ear issues—is frequently present from birth (congenital) but can develop later [10][11].

Lymphedema typically involves swelling in the legs and may appear as early as 6 months of age or later in childhood or adulthood [12][13]. While these symptoms can be life-altering, they are generally not life-threatening on their own.

The Most Serious Risk: MDS and Leukemia

The most critical part of Emberger syndrome is the high risk of developing bone marrow problems. These include Myelodysplastic Syndrome (MDS)—a condition where the bone marrow doesn’t produce enough healthy blood cells—and Acute Myeloid Leukemia (AML), a type of blood cancer [14][15].

  • Timing: While the risk of MDS or AML tends to increase with age, it can occur in infants, children, or adults [14]. There is no safe age cutoff, which is why monitoring begins at diagnosis.
  • Monitoring: Because marrow disease can progress quickly, regular bone marrow exams and blood tests are used to catch changes early [16].
  • Treatment: Currently, the definitive treatment for the bone marrow and immune system issues is an allogeneic hematopoietic stem cell transplant (bone marrow transplant) [7][17].

Why the Correct Name Matters

It is vital to distinguish Emberger syndrome from other conditions that might look similar. In the past, it was sometimes confused with MYH9-related disease because both can cause hearing loss and low platelet counts [18][19].

However, they are very different:

  • Emberger Syndrome (GATA2 deficiency): Carries a high risk of leukemia and causes significant immune system deficiencies [15][7].
  • MYH9-Related Disease: Does not cause leukemia or the specific immune cell losses seen in GATA2 deficiency [20].

Distinguishing between the two requires specific genetic testing for the GATA2 gene. This ensures the correct monitoring for bone marrow and immune health [2].

Managing Infections and Lung Health

Because the immune system may lack key “soldiers” like monocytes and NK cells, patients are more susceptible to certain infections [5]. These can include persistent warts or other skin issues caused by Human Papillomavirus (HPV), as well as serious lung infections [7][21].

Some individuals also develop Pulmonary Alveolar Proteinosis (PAP), a condition where proteins build up in the air sacs of the lungs, making it hard to breathe [22]. Regular check-ups with an immunology specialist and a lung doctor (pulmonologist) are essential parts of the care team [23].

Moving Forward

Finding out you or your child has an extremely rare syndrome is daunting. However, because we now know the genetic cause is GATA2, doctors can use a proactive strategy. By monitoring the bone marrow closely, the care team can decide on the best timing for a transplant before serious complications arise [24][3]. Working with a specialized center that has experience in GATA2 deficiency is the best way to navigate these complex needs.

Common questions in this guide

What is Emberger syndrome and what causes it?
Emberger syndrome is a rare genetic condition caused by a pathogenic variant in the GATA2 gene. GATA2 helps the body make blood cells and develop the immune, lymphatic, and inner-ear systems. The condition is also called deafness-lymphedema-leukemia syndrome and is part of the GATA2 deficiency group.
What are the main signs of GATA2 deficiency?
Common features include sensorineural hearing loss and lymphedema, or long-lasting swelling, often in the legs. Some people develop infections, persistent HPV-related warts, or serious lung infections because certain immune cells are low. Timing and severity vary widely.
Does Emberger syndrome increase the risk of leukemia?
Yes. People with Emberger syndrome have an increased risk of myelodysplastic syndrome and acute myeloid leukemia, and these problems can occur in infancy, childhood, or adulthood. Regular blood tests and bone marrow exams are used to look for changes early.
How is Emberger syndrome diagnosed?
Genetic testing can identify a pathogenic GATA2 variant and help distinguish Emberger syndrome from conditions such as MYH9-related disease. Doctors may also use blood tests and bone marrow exams to assess blood-cell production and detect myelodysplastic syndrome or leukemia. The results help determine the monitoring plan.
What treatment is used for GATA2 deficiency?
An allogeneic hematopoietic stem cell transplant, also called a bone marrow transplant, is currently the definitive treatment for the bone marrow and immune-system problems caused by GATA2 deficiency. The care team uses blood and bone marrow monitoring to help decide when transplant is most appropriate. Timing depends on the person’s findings and overall situation.
What infections and lung problems should people with Emberger syndrome watch for?
Low levels of certain immune cells can increase susceptibility to persistent HPV-related warts, unusual bacterial infections, and serious lung infections. Some people develop pulmonary alveolar proteinosis, in which proteins build up in the lung air sacs and make breathing difficult. Regular care with an immunology specialist and pulmonologist helps monitor these risks.

Get notified when new evidence is published on Deafness-lymphedema-leukemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (24)
  1. 1

    GATA 2 Deficiency: Focus on Immune System Impairment.

    Fabozzi F, Mastronuzzi A, Ceglie G, et al.

    Frontiers in immunology 2022; (13()):865773 doi:10.3389/fimmu.2022.865773.

    PMID: 35769478
  2. 2

    The spectrum of GATA2 deficiency syndrome.

    Calvo KR, Hickstein DD

    Blood 2023; (141(13)):1524-1532 doi:10.1182/blood.2022017764.

    PMID: 36455197
  3. 3

    The different faces of GATA2 deficiency: implications for therapy and surveillance.

    Vinci L, Strahm B, Speckmann C, Erlacher M

    Frontiers in oncology 2024; (14()):1423856 doi:10.3389/fonc.2024.1423856.

    PMID: 38993648
  4. 4

    Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.

    Wu Z, Gao S, Diamond C, et al.

    Blood advances 2020; (4(12)):2656-2670 doi:10.1182/bloodadvances.2019001352.

    PMID: 32556286
  5. 5

    Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.

    Nováková M, Žaliová M, Suková M, et al.

    Haematologica 2016; (101(6)):707-16 doi:10.3324/haematol.2015.137711.

    PMID: 27013649
  6. 6

    GATA2 regulates dendritic cell differentiation.

    Onodera K, Fujiwara T, Onishi Y, et al.

    Blood 2016; (128(4)):508-18 doi:10.1182/blood-2016-02-698118.

    PMID: 27259979
  7. 7

    GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.

    Rajput RV, Arnold DE

    Current hematologic malignancy reports 2023; (18(4)):89-97 doi:10.1007/s11899-023-00695-7.

    PMID: 37247092
  8. 8

    GATA2 is required for lymphatic vessel valve development and maintenance.

    Kazenwadel J, Betterman KL, Chong CE, et al.

    The Journal of clinical investigation 2015; (125(8)):2979-94.

    PMID: 26214525
  9. 9

    GATA2 Deficiency Syndrome: A Case Series and Literature Review.

    Dong Z, Lai J, Li J, et al.

    Journal of clinical immunology 2026; (46(1)).

    PMID: 41870648
  10. 10

    Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation.

    Rastogi N, Abraham RS, Chadha R, et al.

    Journal of pediatric hematology/oncology 2018; (40(6)):e383-e388 doi:10.1097/MPH.0000000000000995.

    PMID: 29189513
  11. 11

    [Congenital deaf-mutism with pale complexion and anemia for 1 year in a school-aged girl].

    Chen LL, He XL, Chen KK

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2019; (21(11)):1105-1109.

    PMID: 31753093
  12. 12

    Many signs, one mutation: Early onset of de novo GATA2 deficiency syndrome. A case report.

    Blanco ML, Torrent M, Bussaglia E, et al.

    Clinical case reports 2020; (8(12)):3193-3197 doi:10.1002/ccr3.3304.

    PMID: 33363905
  13. 13

    A Rare Case of Emberger Syndrome Caused By a De Novo Mutation in the GATA2 Gene.

    Michelini S, Cardone M, Haag M, et al.

    Lymphology 2016; (49(1)):15-20.

    PMID: 29906059
  14. 14

    Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency.

    Kotmayer L, Kozyra EJ, Kang G, et al.

    Blood cancer journal 2025; (15(1)):121 doi:10.1038/s41408-025-01309-6.

    PMID: 40664679
  15. 15

    GATA2 deficiency syndrome: A decade of discovery.

    Homan CC, Venugopal P, Arts P, et al.

    Human mutation 2021; (42(11)):1399-1421 doi:10.1002/humu.24271.

    PMID: 34387894
  16. 16

    Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium.

    Sicre de Fontbrune F, Chevillon F, Fahd M, et al.

    British journal of haematology 2026; (208(1)):250-258 doi:10.1111/bjh.19691.

    PMID: 39159950
  17. 17

    Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.

    Bortnick R, Wlodarski M, de Haas V, et al.

    Bone marrow transplantation 2021; (56(11)):2732-2741 doi:10.1038/s41409-021-01374-y.

    PMID: 34244664
  18. 18

    MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy.

    Fernandez-Prado R, Carriazo-Julio SM, Torra R, et al.

    Clinical kidney journal 2019; (12(4)):488-493 doi:10.1093/ckj/sfz103.

    PMID: 31384439
  19. 19

    Linking the Landscape of MYH9-Related Diseases to the Molecular Mechanisms that Control Non-Muscle Myosin II-A Function in Cells.

    Asensio-Juárez G, Llorente-González C, Vicente-Manzanares M

    Cells 2020; (9(6)) doi:10.3390/cells9061458.

    PMID: 32545517
  20. 20

    Familial macro thrombocytopenia: role of genetics where morphology fails.

    Chaudhary H, Jindal A, Guleria S, et al.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2020; (31(5)):333-334 doi:10.1097/MBC.0000000000000923.

    PMID: 32516168
  21. 21

    Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency.

    Parta M, Cole K, Avila D, et al.

    Transplantation and cellular therapy 2021; (27(5)):435.e1-435.e11 doi:10.1016/j.jtct.2020.12.028.

    PMID: 33965189
  22. 22

    Pulmonary Manifestations of GATA2 Deficiency.

    Marciano BE, Olivier KN, Folio LR, et al.

    Chest 2021; (160(4)):1350-1359 doi:10.1016/j.chest.2021.05.046.

    PMID: 34089740
  23. 23

    [GATA2 gene mutations: 3 cases].

    Perrard N, Pokeerbux MR, Quesnel B, et al.

    La Revue de medecine interne 2022; (43(11)):677-682 doi:10.1016/j.revmed.2022.08.007.

    PMID: 36041908
  24. 24

    GATA2 and marrow failure.

    Fabozzi F, Strocchio L, Mastronuzzi A, Merli P

    Best practice & research. Clinical haematology 2021; (34(2)):101278 doi:10.1016/j.beha.2021.101278.

    PMID: 34404529

This page is for informational purposes only and does not constitute medical advice. A hematologist, genetic specialist, and other members of your care team can interpret your results and recommend monitoring and treatment.

Guide contents Deafness-lymphedema-leukemia syndrome
Research & Literature
02 The Biology and Diagnosis of GATA2 Deficiency